Cyclins and Breast Cancer

The D-type and E-type cyclins control the G1 to S phase transition during normal cell cycle progression and are critical components of steroid- and growth factor-induced mitogenesis in breast epithelial cells. Mammary epithelial cell-specific overexpression of these genes leads to mammary carcinoma, while in cyclin D1-deficient mice mammary gland development is arrested prior to lobuloalveolar development. Cyclin D1 null mice are resistant to mammary carcinoma induced by the neu and ras oncogenes, indicating an essential role for cyclin D1 in the development of some mammary cancers. Cyclin D1 and E1 are commonly overexpressed in primary breast cancer, with some evidence of an association with an adverse patient outcome. This observation may result in part from their ability to confer resistance to endocrine therapies. The functional consequences of cyclin E overexpression in breast cancer are likely related to its role in cell cycle progression, whereas that of cyclin D1 may also be a consequence of a more recently defined role in transcriptional regulation.

[1]  C. Zahnow,et al.  Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer. , 1997, Journal of the National Cancer Institute.

[2]  G. Colditz,et al.  Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. , 1998, Journal of the National Cancer Institute.

[3]  D. Birnbaum,et al.  Localization of 11q13 loci with respect to regional chromosomal breakpoints. , 1992, Genomics.

[4]  R. Sutherland,et al.  Inducible expression of cyclin D1 in T‐47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation , 1996, Journal of cellular biochemistry.

[5]  Dulic,et al.  老化ヒト二倍体線維芽細胞におけるG1サイクリン調節の変化 不活性サイクリンE‐Cdk2及びサイクリンD1‐Cdk2複合体 , 1993 .

[6]  M. Pagano,et al.  Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. , 1994, Oncogene.

[7]  J. Carroll,et al.  Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells. , 2002, Cancer research.

[8]  M. J. van de Vijver,et al.  Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. , 1992, Cancer research.

[9]  J. Lamb,et al.  Regulation of the Functional Interaction between Cyclin D1 and the Estrogen Receptor , 2000, Molecular and Cellular Biology.

[10]  G. Peters,et al.  Chromosome 11q13 markers and D-type cyclins in breast cancer , 2004, Breast Cancer Research and Treatment.

[11]  L. Hengst,et al.  A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells , 1994, Molecular and cellular biology.

[12]  J. Barrett,et al.  Investigation of the role of G1/S cell cycle mediators in cellular senescence. , 1993, Experimental cell research.

[13]  T. Hunter,et al.  Cyclins and cancer , 1991, Cell.

[14]  Z. Darżynkiewicz,et al.  Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines. , 1994, Cancer research.

[15]  J.M. Adams,et al.  Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. , 1994, The EMBO journal.

[16]  D. Beach,et al.  Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. , 1993, Genes & development.

[17]  J. Bishop Molecular themes in oncogenesis , 1991, Cell.

[18]  R. Sutherland,et al.  Mechanisms of Cyclin-Dependent Kinase Inactivation by Progestins , 1998, Molecular and Cellular Biology.

[19]  R. Weinberg,et al.  Tumor suppressor genes. , 1994, Current opinion in genetics & development.

[20]  L. M. Facchini,et al.  Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. , 1994, Oncogene.

[21]  T. Meeker,et al.  Amplification and expression of the bcl-1 gene in human solid tumor cell lines. , 1992, Cancer research.

[22]  Sehwan Han,et al.  Cyclin D1 expression and patient outcome after tamoxifen therapy in estrogen receptor positive metastatic breast cancer. , 2003, Oncology reports.

[23]  D. Givol,et al.  A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1. , 1994, Oncogene.

[24]  S. Weitzman,et al.  Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. , 2001, Cancer research.

[25]  P. Leder,et al.  Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene , 1988, Cell.

[26]  J. Slingerland,et al.  Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Sutherland,et al.  Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Bartek,et al.  Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint , 1996, Molecular and cellular biology.

[29]  M. Skolnick,et al.  A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.

[30]  L. Bonetta,et al.  CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1. , 1994, Oncogene.

[31]  J. Bartek,et al.  Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. , 1994, Cancer research.

[32]  R. Weinberg,et al.  Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution , 1997, Molecular and cellular biology.

[33]  J. Massagué,et al.  Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27 Kip1 ) of cyclin-dependent kinase 4 activation , 1994, Cell.

[34]  J. Varley,et al.  Structural rearrangement of the retinoblastoma gene in human breast carcinoma. , 1988, Science.

[35]  D. Birnbaum,et al.  Patterns of dna amplification at band q13 of chromosome 11 in human breast cancer , 1994, Genes, chromosomes & cancer.

[36]  Isabelle Bedrosian,et al.  Cyclin E and survival in patients with breast cancer. , 2002, The New England journal of medicine.

[37]  G. Hannon,et al.  Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair , 1994, Nature.

[38]  G. Peters,et al.  Chromosome 11q13 abnormalities in human breast cancer. , 1993, Cancer surveys.

[39]  E. Schuuring,et al.  Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. , 1992, Oncogene.

[40]  R. Sutherland,et al.  Estrogen-induced Activation of Cdk4 and Cdk2 during G1-S Phase Progression Is Accompanied by Increased Cyclin D1 Expression and Decreased Cyclin-dependent Kinase Inhibitor Association with Cyclin E-Cdk2* , 1997, The Journal of Biological Chemistry.

[41]  B. Leung,et al.  Mode of estrogen action on cell proliferation in CAMA‐1 cells: II. Sensitivity of G1 phase population , 1987, Journal of cellular biochemistry.

[42]  J. Nevins,et al.  Expression of transcription factor E2F1 induces quiescent cells to enter S phase , 1993, Nature.

[43]  Richard Simon,et al.  Initiating oncogenic event determines gene-expression patterns of human breast cancer models , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A. Okamoto,et al.  IS-12 Mutation and altered expression of P16^ in human cancer. , 1995 .

[45]  David O. Morgan,et al.  Principles of CDK regulation , 1995, Nature.

[46]  F. Zindy,et al.  Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma. , 1992, Oncogene.

[47]  J. Pollard,et al.  Genetic Evidence for the Interactions of Cyclin D1 and p27Kip1 in Mice , 2001, Molecular and Cellular Biology.

[48]  J. A. Hamilton,et al.  Expression and amplification of cyclin genes in human breast cancer. , 1993, Oncogene.

[49]  H. Frierson,et al.  Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[50]  S. Elledge,et al.  p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells , 1995, Science.

[51]  Y. Xiong,et al.  Both p16 and p21 Families of Cyclin-dependent Kinase (CDK) Inhibitors Block the Phosphorylation of Cyclin-dependent Kinases by the CDK-activating Kinase (*) , 1995, The Journal of Biological Chemistry.

[52]  Charles J. Sherr,et al.  Mammalian G1 cyclins , 1993, Cell.

[53]  R. Gill,et al.  Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. , 1995, Oncogene.

[54]  N. Rosen,et al.  A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line. , 1994, Oncogene.

[55]  R. Blamey,et al.  Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[56]  R. Sutherland,et al.  Regulation of breast cancer cell cycle progression by growth factors, steroids and steroid antagonists , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[57]  G. Peters,et al.  Chromosome 11q13 abnormalities in human cancer. , 1991, Cancer cells.

[58]  F. Ajchenbaum‐Cymbalista,et al.  Regulation of G1/S transition by cyclins D2 and D3 in hematopoietic cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Foekens,et al.  Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment. , 1995, Gene.

[60]  K. Matsumoto,et al.  Cloning of a human cDNA encoding a CDC2-related kinase by complementation of a budding yeast cdc28 mutation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[61]  J. Nevins,et al.  Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A , 1991, Cell.

[62]  M. Gossen,et al.  Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. , 1994, Molecular and cellular biology.

[63]  D. Birnbaum,et al.  BCL-1 participates in the 11q13 amplification found in breast cancer. , 1990, Oncogene.

[64]  W. Clark,et al.  Germline p16 mutations in familial melanoma , 1994, Nature Genetics.

[65]  S. Shurtleff,et al.  D-type cyclin-dependent kinase activity in mammalian cells , 1994, Molecular and cellular biology.

[66]  K. Keyomarsi,et al.  Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene. , 1992, The Journal of biological chemistry.

[67]  J. A. Hamilton,et al.  Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. , 1993, Molecular and cellular biology.

[68]  S. Shurtleff,et al.  Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. , 1993, Genes & development.

[69]  G. Hannon,et al.  p21-containing cyclin kinases exist in both active and inactive states. , 1994, Genes & development.

[70]  J. Slingerland,et al.  Constitutive MEK/MAPK Activation Leads to p27Kip1Deregulation and Antiestrogen Resistance in Human Breast Cancer Cells* , 2001, The Journal of Biological Chemistry.

[71]  A. Arnold,et al.  Clonal loss of one chromosome 11 in a parathyroid adenoma. , 1989, The Journal of clinical endocrinology and metabolism.

[72]  R. Sutherland,et al.  Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle. , 1989, Cancer research.

[73]  P. W. Janes,et al.  Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells , 1998, Oncogene.

[74]  R. Weinberg,et al.  Physical interaction of the retinoblastoma protein with human D cyclins , 1993, Cell.

[75]  C. Theillet,et al.  Amplification of 11q13 DNA sequences in human breast cancer: D11S97 identifies a region tightly linked to BCL1 which can be amplified separately. , 1992, Oncogene.

[76]  Gregory J. Hannon,et al.  pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest , 1994, Nature.

[77]  J. Fontana Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation. , 1987, Experimental cell biology.

[78]  C. Sherr G1 phase progression: Cycling on cue , 1994, Cell.

[79]  R. Sutherland,et al.  Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[80]  A. Okamoto,et al.  Mutations and altered expression of p16INK4 in human cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[81]  B. Henderson,et al.  Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture. , 1988, Cancer research.

[82]  A. Arnold,et al.  Cyclins and oncogenesis. , 1993, Biochimica et biophysica acta.

[83]  J. Bartek,et al.  Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types. , 1995, Oncogene.

[84]  C. Sherr,et al.  Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase , 1994, Molecular and cellular biology.

[85]  D. Louis,et al.  Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas. , 1994, Cancer research.

[86]  S. Hirohashi,et al.  Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. , 1989, Cancer research.

[87]  M. Pagano,et al.  Cyclin D1 is a nuclear protein required for cell cycle progression in G1. , 1993, Genes & development.

[88]  James M. Roberts,et al.  A link between cyclin A expression and adhesion-dependent cell cycle progression. , 1993, Science.

[89]  M. Barbacid,et al.  To cycle or not to cycle: a critical decision in cancer , 2001, Nature reviews. Cancer.

[90]  M. Sheikh,et al.  Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. , 1994, Oncogene.

[91]  T. Hunter,et al.  Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.

[92]  J. Labbé,et al.  Inhibition of cAMP‐dependent protein kinase plays a key role in the induction of mitosis and nuclear envelope breakdown in mammalian cells. , 1991, The EMBO journal.

[93]  D. Sidransky,et al.  Rates of p16 (MTS1) mutations in primary tumors with 9p loss. , 1994, Science.

[94]  D. Rowitch,et al.  Development of mice expressing a single D-type cyclin. , 2002, Genes & development.

[95]  T. Oyama,et al.  Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. , 1998, Cancer research.

[96]  M. Sporn,et al.  The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta. , 1991, The Journal of clinical investigation.

[97]  Y. Geng,et al.  Specific protection against breast cancers by cyclin D1 ablation , 2001, Nature.

[98]  Andrew W. Murray,et al.  The role of cyclin synthesis and degradation in the control of maturation promoting factor activity , 1989, Nature.

[99]  James M. Roberts,et al.  Cloning of p27 Kip1 , a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals , 1994, Cell.

[100]  D. Barnes,et al.  Cyclin D1 in Breast Cancer , 2004, Breast Cancer Research and Treatment.

[101]  I W Taylor,et al.  Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells. , 1983, Cancer research.

[102]  D. Carson,et al.  Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers , 1994, Nature.

[103]  R. Sutherland,et al.  Expression of the cyclin‐dependent kinase inhibitors p16INK4, p15INK4B and p21Waf1/cip1 in human breast cancer , 1995, International journal of cancer.

[104]  J. Bartek,et al.  Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. , 1990, Oncogene.

[105]  S. Elledge,et al.  Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[106]  A. Kamb,et al.  Cell-cycle regulators and cancer. , 1995, Trends in genetics : TIG.

[107]  R. Bronson,et al.  Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[108]  I. Bièche,et al.  Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays , 2002, British Journal of Cancer.

[109]  F. C. Lucibello,et al.  Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E. , 1994, Oncogene.

[110]  L. Altucci,et al.  17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. , 1996, Oncogene.

[111]  K. Keyomarsi,et al.  Redundant cyclin overexpression and gene amplification in breast cancer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[112]  R. Blamey,et al.  Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[113]  Robert L. Sutherland,et al.  Cyclin D1, EMS1 and 11q13 Amplification in Breast Cancer , 2003, Breast Cancer Research and Treatment.

[114]  O. Melnyk,et al.  Characterization of a candidate bcl-1 gene , 1991, Molecular and cellular biology.

[115]  J. Bartek,et al.  Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. , 1995, Oncogene.

[116]  R. Sutherland,et al.  Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells. , 2000, Molecular and cellular biology.

[117]  G. Hannon,et al.  The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA , 1994, Nature.

[118]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[119]  D. Bortner,et al.  Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E , 1997, Molecular and cellular biology.

[120]  R. Derynck,et al.  Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells , 1987, Cell.

[121]  D. Givol,et al.  Induction of WAF1/CIP1 by a p53-independent pathway. , 1994, Cancer research.

[122]  S. Reed,et al.  Different roles for cyclins D1 and E in regulation of the G1-to-S transition , 1995, Molecular and cellular biology.

[123]  M. Ewen,et al.  Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4 , 1997, Molecular and cellular biology.

[124]  J. Griffin,et al.  Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells. , 1995, Oncogene.

[125]  A. Gartel,et al.  Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[126]  T. Golub,et al.  A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer , 2003, Cell.

[127]  C. Bréchot,et al.  Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma , 1990, Nature.

[128]  J. Henry,et al.  int‐2 Amplification in breast cancer: Association with decreased survival and relationship to amplification of c‐erbb‐2 and c‐myc , 1993, International journal of cancer.

[129]  S. Elledge,et al.  Cyclin D1 provides a link between development and oncogenesis in the retina and breast , 1995, Cell.

[130]  R. Sutherland,et al.  Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21. , 1997, Molecular endocrinology.

[131]  P. Nurse,et al.  Animal cell cycles and their control. , 1992, Annual review of biochemistry.

[132]  C. Guillouf,et al.  Induction of p21 (WAF-1/CIP1) during differentiation. , 1994, Oncogene.

[133]  F. C. Lucibello,et al.  Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. , 1994, Oncogene.

[134]  R. Shiu,et al.  Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. , 1987, Cancer research.

[135]  R. Mehta,et al.  Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor. , 1989, Carcinogenesis.

[136]  R. Bernards,et al.  CDK-Independent Activation of Estrogen Receptor by Cyclin D1 , 1997, Cell.

[137]  J. S. Foster,et al.  Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. , 1996, Molecular endocrinology.

[138]  Jun Kato,et al.  Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[139]  Rene H Medema,et al.  Rescue of Cyclin D1 Deficiency by Knockin Cyclin E , 1999, Cell.

[140]  C. Clarke,et al.  Progestin regulation of cellular proliferation. , 1990, Endocrine reviews.

[141]  U. Francke,et al.  The Vin-1 gene, identified by provirus insertional mutagenesis, is the cyclin D2. , 1993, Oncogene.

[142]  R. Sutherland,et al.  c-Myc or Cyclin D1 Mimics Estrogen Effects on Cyclin E-Cdk2 Activation and Cell Cycle Reentry , 1998, Molecular and Cellular Biology.

[143]  M. Pagano,et al.  Differential modulation of cyclin gene expression by MYC. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[144]  R. Sutherland,et al.  Cyclin D1 Overexpression Induces Progestin Resistance in T-47D Breast Cancer Cells Despite p27Kip1 Association with Cyclin E-Cdk2* , 2001, The Journal of Biological Chemistry.

[145]  S. Reed,et al.  Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[146]  James M. Roberts,et al.  Cyclin-dependent regulation of G1 in mammalian fibroblasts. , 1993, Science.

[147]  F. Orr,et al.  C‐myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells , 2002, International journal of cancer.

[148]  J. LaBaer,et al.  New functional activities for the p21 family of CDK inhibitors. , 1997, Genes & development.

[149]  J. Peterse,et al.  A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. , 1996, British Journal of Cancer.

[150]  E. Schuuring,et al.  D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. , 1991, Oncogene.

[151]  David Beach,et al.  p21 is a universal inhibitor of cyclin kinases , 1993, Nature.

[152]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[153]  M. Dyer,et al.  BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation. , 1994, Oncogene.

[154]  S. Reed,et al.  Association of human cyclin E with a periodic G1-S phase protein kinase. , 1992, Science.

[155]  J. R. Smith,et al.  Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. , 1994, Experimental cell research.

[156]  R. Hruban,et al.  Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma , 1994, Nature Genetics.

[157]  J. Carroll,et al.  A Pure Estrogen Antagonist Inhibits Cyclin E-Cdk2 Activity in MCF-7 Breast Cancer Cells and Induces Accumulation of p130-E2F4 Complexes Characteristic of Quiescence* , 2000, The Journal of Biological Chemistry.

[158]  Z. Su,et al.  Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. , 1994, Oncogene.

[159]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[160]  C. Sweep,et al.  Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer , 2003, Oncogene.

[161]  David M. Livingston,et al.  Functional interactions of the retinoblastoma protein with mammalian D-type cyclins , 1993, Cell.

[162]  W. Lee,et al.  Inactivation of the retinoblastoma susceptibility gene in human breast cancers. , 1988, Science.

[163]  N. Harris,et al.  PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[164]  D. Horsfall,et al.  Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[165]  B. Angus,et al.  Determination of the prognostic value of cyclin D1 overexpression in breast cancer. , 1995, Oncogene.

[166]  M. Ewen,et al.  Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. , 1993, Genes & development.

[167]  J. Carroll,et al.  Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens. , 2002, Cancer research.

[168]  J. Bartek,et al.  Molecular pathology of the cell cycle in human cancer cells , 1993, Stem cells.

[169]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[170]  S. Elledge,et al.  CDK2 encodes a 33-kDa cyclin A-associated protein kinase and is expressed before CDC2 in the cell cycle. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[171]  P. Watkins,et al.  Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells. , 1992, Cancer genetics and cytogenetics.

[172]  M. Merino,et al.  Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions , 1995, Nature Medicine.

[173]  M. Ewen,et al.  TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest , 1993, Cell.

[174]  A. deFazio,et al.  Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation. , 1995, Molecular endocrinology.

[175]  C. Theillet,et al.  Proto-oncogene amplification and human breast tumor phenotype. , 1989, Oncogene.

[176]  R. Fotedar,et al.  Cell cycle regulated phosphorylation of RPA‐32 occurs within the replication initiation complex. , 1992, The EMBO journal.

[177]  James M. Roberts,et al.  Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients , 1997, Nature Medicine.

[178]  T. Hwang,et al.  Prognostic value of combined analysis of cyclin D1 and estrogen receptor status in breast cancer patients , 2003, Pathology international.

[179]  J. Bartek,et al.  Cyclin D1 expression is regulated by the retinoblastoma protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[180]  E. Lees,et al.  Cyclin E, a potential prognostic marker for breast cancer. , 1994, Cancer research.

[181]  P. Leder,et al.  Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo , 1987, Cell.

[182]  R. Pepperkok,et al.  Cyclin A is required at two points in the human cell cycle. , 1992, The EMBO journal.

[183]  M. Kirschner,et al.  Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA , 1995, Nature.

[184]  G. Hannon,et al.  Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD , 1995, Science.

[185]  A. Knudson,et al.  Antioncogenes and human cancer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[186]  K. Alitalo,et al.  Repression of cyclin D1: a novel function of MYC. , 1994, Molecular and cellular biology.

[187]  P. Leder,et al.  Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes , 1984, Cell.

[188]  J. Carroll,et al.  p27Kip1 Induces Quiescence and Growth Factor Insensitivity in Tamoxifen-treated Breast Cancer Cells , 2003 .

[189]  J. Roberts,et al.  Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes , 1994, Molecular and cellular biology.

[190]  Robert L Sutherland,et al.  Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells , 1998, Oncogene.

[191]  R. Sutherland,et al.  Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells , 1997, Oncogene.

[192]  R. Cardiff,et al.  Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution. , 2001, Cancer research.

[193]  E. Nigg,et al.  Targets of cyclin-dependent protein kinases. , 1993, Current opinion in cell biology.

[194]  D. Eick,et al.  Structure and cell cycle-regulated transcription of the human cyclin A gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[195]  G. Peters,et al.  Lack of cyclin D‐Cdk complexes in Rb‐negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. , 1995, The EMBO journal.

[196]  R. Weinberg,et al.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins , 1992, Cell.

[197]  C. O'keefe,et al.  Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. , 1994, Genes & development.

[198]  D. Medina,et al.  Mouse mammary hyperplasias and neoplasias exhibit different patterns of cyclins D1 and D2 binding to cdk4. , 1995, Carcinogenesis.

[199]  Peter A. Jones,et al.  P16 gene in uncultured tumours , 1994, Nature.

[200]  Hui Zhang,et al.  D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA , 1992, Cell.

[201]  G. Landberg,et al.  The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node , 2002, Oncogene.

[202]  Z. Darżynkiewicz,et al.  Simultaneous analysis of cell cycle kinetics at two different DNA ploidy levels based on DNA content and cyclin B measurements. , 1993, Cancer research.

[203]  James M. Roberts,et al.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. , 1994, Genes & development.

[204]  R. Sutherland,et al.  Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[205]  G. Thomas,et al.  Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. , 1995, Oncogene.

[206]  D. Medina,et al.  Cell cyclins and cyclin-dependent kinase activities in mouse mammary tumor development. , 1995, Carcinogenesis.

[207]  M. Pagano,et al.  Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. , 1994, Genes & development.

[208]  H. Lovec,et al.  Cyclin D1/bcl‐1 cooperates with myc genes in the generation of B‐cell lymphoma in transgenic mice. , 1994, The EMBO journal.

[209]  S. Reed,et al.  G1-specific cyclins: in search of an S-phase-promoting factor. , 1991, Trends in genetics : TIG.

[210]  James M. Roberts,et al.  Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle , 1992 .

[211]  J. Foekens,et al.  Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors. , 1992, European journal of cancer.

[212]  Emma Lees,et al.  Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice , 1994, Nature.

[213]  O. Coqueret Linking cyclins to transcriptional control. , 2002, Gene.

[214]  G. Hannon,et al.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.

[215]  J. Norton,et al.  Genetic abnormalities in sporadic parathyroid adenomas. , 1990, The Journal of clinical endocrinology and metabolism.

[216]  F. Kittrell,et al.  Functional analysis of cyclin D2 and p27Kip1 in cyclin D2 transgenic mouse mammary gland during development , 2002, Oncogene.

[217]  G. Peters,et al.  Cyclin D1 and prognosis in human breast cancer , 1996, International journal of cancer.

[218]  Sutherland Rl,et al.  Cell cycle control by steroid hormones. , 1994 .

[219]  S. Kato,et al.  Cyclin E as a Coactivator of the Androgen Receptor , 2000, The Journal of cell biology.

[220]  N. Dyson The regulation of E2F by pRB-family proteins. , 1998, Genes & development.

[221]  Jiri Bartek,et al.  Cyclin D1 protein expression and function in human breast cancer , 1994, International journal of cancer.

[222]  R. Weinberg,et al.  Function of a human cyclin gene as an oncogene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[223]  R. Eddy,et al.  Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. , 1989, The Journal of clinical investigation.

[224]  J. Bartek,et al.  DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1 , 1994, The Journal of cell biology.

[225]  M. Fernö,et al.  Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. , 1991, British Journal of Cancer.

[226]  James M. Roberts,et al.  Inhibitors of mammalian G1 cyclin-dependent kinases. , 1995, Genes & development.

[227]  G. Stamp,et al.  Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. , 1995, Genes & development.

[228]  W. Hong,et al.  Overexpression of E2F‐1 in rat embryo fibroblasts leads to neoplastic transformation. , 1994, The EMBO journal.

[229]  D. Germain,et al.  Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer , 1999, Oncogene.

[230]  T. Möröy,et al.  The Oncogenic Activity of Cyclin E Is Not Confined to Cdk2 Activation Alone but Relies on Several Other, Distinct Functions of the Protein* , 2002, The Journal of Biological Chemistry.

[231]  F. Beuvon,et al.  Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: A role for hematopoietic growth factor release by tumor cells? , 1990, Journal of cellular biochemistry.

[232]  J. Carroll,et al.  A Low Abundance Pool of Nascent p21WAF1/Cip1 Is Targeted by Estrogen to Activate Cyclin E·Cdk2* , 2001, The Journal of Biological Chemistry.

[233]  C. Zahnow,et al.  Overexpression of C/EBPβ-LIP, a Naturally Occurring, Dominant-Negative Transcription Factor, in Human Breast Cancer , 1997 .

[234]  Pengcheng Zhou,et al.  Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. , 1993, Oncogene.

[235]  M. Sporn,et al.  MINIREVIEW: Interactions of Retinoids and Transforming Growth Factor-β in Regulation of Cell Differentiation and Proliferation , 1991 .

[236]  R. Sutherland,et al.  Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells , 2004, Breast Cancer Research and Treatment.

[237]  J. Nevins,et al.  Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: A novel mechanism for E1A trans-activation , 1990, Cell.

[238]  B. Stillman,et al.  cdc2 family kinases phosphorylate a human cell DNA replication factor, RPA, and activate DNA replication. , 1992, The EMBO journal.